Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1177/0300891620951863 http://scihub22266oqcxt.onion/10.1177/0300891620951863 32842909!ä!32842909 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Tumori 2021 ; 107 (3): 267-269 Nephropedia Template TP {{tp|p=32842909|t=2021. Interstitial pneumonitis in the COVID-19 era: a difficult differential diagnosis in patients with lung cancer |pdf=|usr=}}{{32842909}} gab.com Text Interstitial pneumonitis in the COVID-19 era: a difficult differential diagnosis in patients with lung cancer JO: Tumori http://www.kidney.de/pget.php?&tw=1&pmid=32842909 #FOAvip In this coronavirus 2019 (COVID-19) era, when pneumonitis occurs in patients with lung cancer receiving immune checkpoint inhibitors (ICIs), a major challenge is to make a rapid and correct differential diagnosis among drug-induced pulmonary toxicity, tumour progression, and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-induced pneumonitis. While waiting for polymerase chain reaction (PCR) testing results, an accurate evaluation of the symptoms and serologic features can help us make a first diagnostic hypothesis and quickly start correct treatment. Physicians need a collaborative effort to develop and share a common database reporting clinical (anosmia, dysgeusia), serologic, and radiologic data in ICI-treated patients with lung cancer developing interstitial disease to create an evidence-based clinical diagnostic algorithm. This tool will continue to be helpful when we emerge from the pandemic crisis into a world in which COVID-19 may not have been eradicated to better select the target population requiring the most resource-consuming PCR tests. Twit Text FOAVip Interstitial pneumonitis in the COVID-19 era: a difficult differential diagnosis in patients with lung cancer ????Tumori http://www.kidney.de/pget.php?&tw=1&pmid=32842909 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32842909 #FOAvip English Wikipedia <ref>{{Cite pmid|32842909}}</ref> Interstitial pneumonitis in the COVID-19 era: a difficult differential diagnosis in patients with lung cancer #MMPMID32842909 Catania C; Stati V; Spitaleri G Tumori 2021[Jun]; 107 (3): 267-269 PMID32842909show ga In this coronavirus 2019 (COVID-19) era, when pneumonitis occurs in patients with lung cancer receiving immune checkpoint inhibitors (ICIs), a major challenge is to make a rapid and correct differential diagnosis among drug-induced pulmonary toxicity, tumour progression, and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-induced pneumonitis. While waiting for polymerase chain reaction (PCR) testing results, an accurate evaluation of the symptoms and serologic features can help us make a first diagnostic hypothesis and quickly start correct treatment. Physicians need a collaborative effort to develop and share a common database reporting clinical (anosmia, dysgeusia), serologic, and radiologic data in ICI-treated patients with lung cancer developing interstitial disease to create an evidence-based clinical diagnostic algorithm. This tool will continue to be helpful when we emerge from the pandemic crisis into a world in which COVID-19 may not have been eradicated to better select the target population requiring the most resource-consuming PCR tests. |Algorithms[MESH] |COVID-19/epidemiology/*prevention & control/virology[MESH] |Diagnosis, Differential[MESH] |Humans[MESH] |Immunotherapy/methods[MESH] |Lung Diseases, Interstitial/*diagnosis[MESH] |Lung Neoplasms/*therapy[MESH] |Pandemics[MESH] |Pneumonia/diagnosis[MESH]Interstitial pneumonitis in the COVID-19 era: a difficult differential(epmc).pdf DeepDyve Pubget Overpricing